One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
Official title: Exercise Testing for Neurological Conditions
Run by Brigham and Women's Hospital · NCT07883720 · Data updated 2026-11-12
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | Brigham and Women's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | July 22, 2026 |
| Main results expected | December 2029 |
| Study ends | December 2029 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07883720 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with epilepsy, functional neurological disorder, mild cognitive impairment, dementia, Parkinson's disease, concussion, or brain tumor, plus healthy controls, who can safely perform maximal effort cycling and undergo MRI.
✕Probably not a fit
Individuals unable to complete maximal cycling or with MRI contraindications may not experience direct benefits from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study enrolls adults with epilepsy, functional neurological disorder, mild cognitive impairment, dementia, Parkinson's disease, concussion, or brain tumors, plus healthy controls, to undergo a single exhaustive exercise session on a bicycle ergometer. Participants have pre- and post-exercise brain MRI scans, blood draws, autonomic measurements, and metabolic assessments, while cardiovascular responses are captured with gas exchange analysis during exercise. The goal is to characterize how fitness, exercise performance, and physical exhaustion relate to neurobiological and physiological changes after a single intense effort, and to compare responses between neurological patients and healthy volunteers.
Why it matters
Potential benefit: If successful, the study could improve understanding of how acute exercise affects brain and autonomic function in neurological diseases, potentially guiding exercise recommendations.
How similar studies have gone: Past work in various neurological groups has shown exercise can influence brain and autonomic measures, but this exact acute, one-day, multi-modal approach in a broad neurological group is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Clinical diagnosis of one of the following neurological diseases: epilepsy, functional neurological disorder, mild cognitive impairment, dementia, Parkinson's disease, concussion, brain tumor \[for participants with neurological diseases\] * No diagnosis of neurological disease \[for healthy control participants\] Exclusion Criteria: * Non-english speaking individuals * Exercise contraindications (e.g., physical impairments limiting use of bicycle ergometer, acute infections, severe heart disease, uncontrolled hypertension, exercise associated seizures) * Current use of medications for cardiac rhythm or rate control * Magnetic resonance imaging (MRI) contraindications (e.g., electrical implants, ferromagnetic implants or objects, pregnancy)
Where it's running
-
Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Claus Reinsberger, MD, PhD — Brigham and Women's Hospital
- Study coordinator: Claus Reinsberger, MD, PhD
- Email: creinsberger@mgb.org
- Phone: 617-804-5828
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Predicting disease progression in dementia using biomarkers and modeling
This study is trying to create a tool that helps predict how dementia will progress in people with mild cognitive impairment and different types of dementia, like Alzheimer's and Lewy Body Disease, by looking at brain scans, body fluids, and mental tests.
-
Remote neuropsychological assessments for patients with neurological disorders
This study is testing a new online way to check brain function in patients with neurological disorders who have trouble getting to appointments.
-
A study on early diagnosis and biomarkers for dementia and related diseases
This study is testing new ways to spot dementia and related diseases early by looking for specific markers in the brain and body, to help people at high risk and track how well new treatments are working.
-
Gut and Oral Microbiome and Cognitive Health in Aging
This study tests whether differences in gut and mouth bacteria are linked to cognitive health in adults across ages and cognitive status.
-
AI-supported sleep program for people with mild cognitive impairment or dementia
A small randomized trial tests an AI-assisted behavioral sleep program to help people with mild cognitive impairment or mild dementia who have sleep problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.